READ SIMON (Chief Scientific Officer) sold 61.6% of their position (10K shares) of RA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $222.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/19/2019ACC: 0001104659-19-036492
Officer· Chief Scientific Officer
Since Feb 2019
-10K
Net shares
Net seller
$222.5K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions3
COMMON STOCK
Direct
Shares
+10K
Price / share
$2.87
Trade value
$28.70K
% of position
160.4%
6/18/2019
6.23K→16.23K
COMMON STOCK
Direct
Shares
−9.59K
Price / share
$22.21
Trade value
$212.91K
% of position
59.0%
6/18/2019
16.23K→6.65K
COMMON STOCK
Direct
Shares
−414.00
Price / share
$23.09
Trade value
$9.56K
% of position
6.2%
6/18/2019
6.65K→6.23K
Total
Net shares
+0.00
Net value
-$193.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK Direct | 6/18/2019 | M · Option Exercise | +10K | $2.87 | $28.70K | 160.4% | 6.23K | 16.23K |
| COMMON STOCK Direct | 6/18/2019 | S · Sale | −9.59K | $22.21 | $212.91K | 59.0% | 16.23K | 6.65K |
| COMMON STOCK Direct | 6/18/2019 | S · Sale | −414.00 | $23.09 | $9.56K | 6.2% | 6.65K | 6.23K |
| Total | +0.00 | -$193.77K | ||||||
Derivative Transactions1
Stock Options (Right to buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
2.87
Held after
106.14K
Exercisable
—
6/18/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy) Direct | Common Stock10K shares | 6/18/2019 | M · Option Exercise | −10K | 2.87 | — | 106.14K |